VA
OLMA icon

VR Adviser’s Olema Pharmaceuticals OLMA Stock Holding History

VR Adviser’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-77,042
Closed -$872K – 43
2024
Q1 		$872K Hold
77,042
– – 0.04% 38
2023
Q4 		$1.08M Hold
77,042
– – 0.07% 36
2023
Q3 		$951K Buy
+77,042
New +$785K 0.1% 35
2022
Q1 		– Sell
-816,651
Closed -$7.64M – 31
2021
Q4 		$7.64M Sell
816,651
-719,542
-47% -$14.9M 1.04% 22
2021
Q3 		$42.3M Hold
1,536,193
– – 5.44% 7
2021
Q2 		$43M Hold
1,536,193
– – 5.21% 7
2021
Q1 		$51M Hold
1,536,193
– – 5.53% 4
2020
Q4 		$73.9M Buy
+1,536,193
New +$72M 10.86% 2

Other funds holding OLMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return